Data regarding the efficacy of the percutaneous coronary intervention (PCI) with new-designed drug-eluting stent (new-DES) vs. bare metal stent (BMS) of saphenous vein grafts (SVG) stenosis is scarce. The primary objective was to compare one-year clinical outcomes of PCI in stenosis of SVG using new-DES vs. BMS in a real-world population. We carried out a multi-center registry comparing new-DES with BMS in all consecutive patients undergoing PCI of SVG. The primary composite endpoint was major adverse cardiac and cerebrovascular events (MACCE) at 1 year.

Inclusion Criteria:

• patients after CABG with significant SVG stenosis referred for PCI

Exclusion Criteria:

• patients who had both types of stents implanted in the same procedure
• patients with the old-DES
• patients who had PCI of other vascular territories during the same procedure

All consecutive patients undergoing PCI of SVG